I guess there is a number of things to consider.
The first would be that at least one Blockbuster gets approved for sale in the USA and elsewhere.
The second would be when these are made available for sale. I assume that confirmatory trials will be required for either or both of them. That's potentially another two years wait, then another months for approval in the US, plus another year for approval in Europe and elsewhere.
The third would be how much money do they need to fund further trials for other indications. I suspect the preclinical pipeline is rather long.
Based on these considerations, a timeframe of five years seems reasonable to me.
MSB Trading - 2020, page-1262
-
- There are more pages in this discussion • 21,899 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 621 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 90.5¢ | 15387 | 3 |
View Market Depth
| Last trade - 09.59am 21/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable